decorin
Recombinant proteinexperimental
Decorin is a protein that in humans is encoded by the DCN gene. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2015 (NCT02865031)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- DecorinSupplementation
DCN supplementation
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDecorin ↗
- ChEMBLCHEMBL4650389 ↗
Also known as
- decorin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03924544 | Phase 1 | Sep 1, 2019 | Cairo University, University of Lubeck |
| NCT02865031 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2015 | Cairo University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cairo University | Academic/Hospital | 2 | 2 | 2 | 2015 |
| University of Lubeck | Academic/Hospital | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1